ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 24,556 Value ($000) $378 Avg Close $19.92 Range $15.14 - $24.64
Q3 2025
Shares 24,556 Value ($000) $503 Avg Close $20.16 Range $17.43 - $24.38
Q2 2025
Shares 21,211 Value ($000) $425 Avg Close $18.93 Range $13.30 - $24.11
Q1 2025
Shares 21,469 Value ($000) $423 Avg Close $21.52 Range $18.67 - $25.37
Q4 2024
Shares 21,746 Value ($000) $489 Avg Close $25.92 Range $21.43 - $30.03
Q3 2024
Shares 20,461 Value ($000) $523 Avg Close $23.16 Range $20.63 - $27.67
Q2 2024
Shares 20,461 Value ($000) $478 Avg Close $21.05 Range $15.96 - $26.00
Q1 2024
Shares 12,345 Value ($000) $217 Avg Close $15.34 Range $10.90 - $19.50
Q4 2023
Shares 12,345 Value ($000) $171 Avg Close $12.23 Range $9.80 - $15.41
Q3 2023
Shares 12,345 Value ($000) $169 Avg Close $16.84 Range $12.38 - $20.77
Q2 2023
Shares 12,345 Value ($000) $252 Avg Close $20.21 Range $17.15 - $23.98